4//SEC Filing
Gad Thomas 4
Accession 0001415889-25-015849
CIK 0001722964other
Filed
Jun 4, 8:00 PM ET
Accepted
Jun 5, 7:17 PM ET
Size
9.1 KB
Accession
0001415889-25-015849
Insider Transaction Report
Form 4
Gad Thomas
DirectorCHIEF BUSINESS OFFICER
Transactions
- Exercise/Conversion
Common Stock
2025-06-03$2.00/sh+103,000$206,000→ 305,721 total - Exercise/Conversion
Employee Stock Option (right to buy)
2025-06-03−103,000→ 0 totalExercise: $2.00Exp: 2025-06-10→ Common Stock (103,000 underlying)
Holdings
- 67,681(indirect: By LLC)
Common Stock
- 60,000(indirect: By Children)
Common Stock
Footnotes (4)
- [F1]Represents shares acquired through the exercise of Employee Stock Options.
- [F2]Reporting Person is sole member of GAD Enterprises, LLC and the sole member and manager of GAD Management, LLC, the manager of GAD Enterprises, LLC, and as such Reporting Person has sole voting and dispositive power with respect to such shares.
- [F3]Represents shares owned by Reporting Person's children who are deemed to share Reporting Person's household.
- [F4]The stock option vested and became exercisable as to 25% of the shares subject to the option on June 10, 2016, and thereafter vested as to 1/48th of the shares in equal monthly installments, until such time as the option was 100% vested on June 10, 2019.
Documents
Issuer
Y-mAbs Therapeutics, Inc.
CIK 0001722964
Entity typeother
Related Parties
1- filerCIK 0001753224
Filing Metadata
- Form type
- 4
- Filed
- Jun 4, 8:00 PM ET
- Accepted
- Jun 5, 7:17 PM ET
- Size
- 9.1 KB